Calliditas • Stockholm • Heltid
The position
As the Supply Chain Manager at Calliditas, you will play a pivotal role in overseeing the supply chains of the launched and upcoming products. Your primary objective will be to ensure the availability of products engaging in tasks such as supply and demand planning, forecasting to suppliers, purchase order management, and collaborating with cross-functional teams to support development projects.
You will report directly to the Supply Chain Director and be a part of the Technical Operations Team. The position will be placed at Calliditas headquarter in central Stockholm.
Key Responsibilities:
Your profile and background
The ideal candidate is ambitious and responsible, willing to take ownership of tasks and unafraid to tackle challenges. You exhibit high stamina and curiosity, and you value collaboration, are attentive to others, and are enthusiastic about sharing thoughts and ideas with the team. You thrive in a cohesive work environment that feels like a family and are committed to working diligently to achieve goals.
You should have the ability to thrive in a fast-paced and dynamic environment with shifting priorities. Your problem-solving skills should reflect innovative thinking and sound decision-making. Moreover, you pay attention to detail and exhibit a structured and efficient work style.
All applications are handled by Bravura Executive.
Calliditas has an exclusive partnership with Bravura Executive regarding this recruitment. We kindly request that other external recruitment companies refrain from contacting us & Calliditas about this job posting.
Reasons to join the Calliditas Team
Welcome to join the Calliditas Team!
About us
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
Calliditas’ lead product, developed under the name Nefecon, has been granted accelerated approval by the FDA under the trade name TARPEYO®, conditional marketing authorization by the European Commission under the trade name KINPEYGO® and by China’s National Medical Products Administration (NMPA) Nefecon®. TARPEYO, KINPEYGO® and Nefecon® are the first and only treatments approved for IgA nephropathy. Calliditas also has a pipeline in orphan-focused indications. Calliditas is conducting a Phase 2b/3 clinical trial in primary biliary cholangitis and a Phase 2 proof-of-concept trial in head and neck cancer with its NOX inhibitor product candidate, Setanaxib.
Calliditas is led by an experienced and dedicated management team with an average of more than 15 years of prior experience in the pharmaceutical industry, including at leading companies such as GlaxoSmithKline, Pfizer and AstraZeneca. The board of directors includes highly qualified researchers, pharmaceutical sector executives and experts in drug development, corporate development and pharmaceutical commercialization. Calliditas is also supported by its Scientific Steering Committee, a highly regarded network of leading experts, that serve as external advisors and investigators on clinical trials.
Calliditas is listed on Nasdaq Stockholm (CALTX) and Nasdaq Global Select Market (CALT)
Calliditas består av ett kreativt team av forskare, kliniker, och andra ämnesexperter som med medkänsla engagerar sig för personer med sällsynta sjukdomar som står inför höga medicinska behov. Vår framgång som företag beror på vår förmåga att fungera som ett enat team, och vi är fast beslutna att tillhandahålla en säker, stimulerande och uppmuntrande miljö där varje anställd ges möjlighet att blomstra och bidra till vårt uppdrag.
För denna tjänst har företaget valt att använda en extern ansökningsprocess. Det betyder att du måste göra ansökan på deras sajt direkt och inte kan söka via Uptrail.